| Document |
Document Title |
|
WO/2023/225117A1 |
The disclosure relates to genetically modified microorganisms, for example of the Genus Paenibacillus, for the improvement of phenotypes of plants, for example nitrogen availability for plants. Included are novel strains of the microorga...
|
|
WO/2023/222098A1 |
Disclosed herein is a UV mutagenesis produced new Streptomyces spororaveus strain SC263 that exhibits an increased thermostability of the antibiotic produced, which shows antibiotic activity against bacteria and fungi. Also provided are ...
|
|
WO/2023/222505A1 |
The present invention relates to a recombinant microbial cell for producing N5-aminopentyl-N- (hydroxy)-succinamic acid of Formula I from at least one simple carbon source wherein the simple carbon source is selected from the group consi...
|
|
WO/2023/222515A1 |
The present invention relates to a recombinant microbial cell for producing at least one compound having structural Formula III from at least one simple carbon source: Formula (III) m = 1-3, wherein the simple carbon source is selected f...
|
|
WO/2023/223869A1 |
The purpose of the present invention is to provide a technology useful for the treatment or diagnosis of cancer. The present invention provides an antitumor agent comprising a purple non-sulfur bacterium isolated from a tumor. The pres...
|
|
WO/2023/221787A1 |
Disclosed are a pichia pastoris engineering strain for a recombinant type I collagen, a construction method therefor and use thereof. A gene sequence for a type I humanized collagen α1 chain mature peptide is synthesized and inserted do...
|
|
WO/2023/224372A1 |
The present invention relates to a Prevotella histicola strain useful for the prevention or treatment of sleep disorders. Prevotella histicola exhibits an increase in total sleep time, non-REM (NREM) sleep time and REM sleep time, and a ...
|
|
WO/2023/223303A1 |
The present invention provides a method to obtain unique cell lines for various applications and systems and methods for a machine learning/AI/Deep Learning software platform that supports the development and optimization of functional i...
|
|
WO/2023/224098A1 |
The present invention addresses the problem of providing a parasitic dinoflagellate which belongs to the genus Amoebophrya and which is effective for controlling a red tide produced by dinoflagellates belonging to the genus Karenia. Pr...
|
|
WO/2023/222602A1 |
The invention refers to a fumonisin-sensitive yeast, specifically Saccharomyces cerevisiae, comprising disrupted or deleted genes SNQ2, PDR12, YOR1, CKA2, LCB3, and optionally any one of VPS51, VPS52, or VPS53 and its use for detecting i...
|
|
WO/2023/224117A1 |
Provided are: a microorganism belonging to the genus Akkermansia, which has a 16S rRNA gene containing a nucleotide sequence having a homology exceeding 98.0% to the nucleotide sequence represented by SEQ ID NO: 3, etc., has NOD2 agonist...
|
|
WO/2023/223993A1 |
Provided is a novel composition for treating ringworm. This composition for treating ringworm contains at least one selected from the group consisting of a bacterial strain of Staphylococcus hominis, a bacterial strain of Staphylococcu...
|
|
WO/2023/223870A1 |
The purpose of the present invention is to provide a technique useful for the treatment or diagnosis of cancer. The present invention provides an antitumor agent including bacteria isolated from a tumor. The bacteria may be, for exampl...
|
|
WO/2023/224153A1 |
The present invention relates to: mutant microorganisms in which genes involved in the production of by-products other than 1,3-propanediol are deleted; and a method for producing 1,3-propanediol using same, wherein the mutant microorgan...
|
|
WO/2023/220796A1 |
The present invention pertains to the biotechnology field aimed at the market of soundproofing and civil engineering articles, packagings, architecture and interior design, and relates, more specifically, to a method for producing fungal...
|
|
WO/2023/224248A1 |
The present application relates to: a microorganism with weakened gluconate repressor protein activity; a method for producing L-arginine by using the microorganism of the present application; a composition for producing L-arginine, comp...
|
|
WO/2023/222075A1 |
The present invention provides a method for increasing a fermentation yield of PF1022A. By using a Rosellinia sp. strain that can produce PF1022A as a production strain, aerobic fermentation is carried out in a fermentation medium. The f...
|
|
WO/2023/221826A1 |
Provided are a gene KWE2 that regulates maize ear grain weight and yield, a protein encoding same, and an expression vector thereof. Further provided are an InDel1 marker of the gene KWE2 that regulates maize ear grain weight and yield, ...
|
|
WO/2023/222956A1 |
The present invention relates to a method for manufacturing a microbial carrier. The method according to the invention aims to produce solid carriers on which microorganisms are immobilized, said supports being intended to be used in var...
|
|
WO/2023/221892A1 |
The present invention relates to antibodies specifically binding to α-Synuclein or antigen-binding fragments thereof, a pharmaceutical composition containing the antibodies or the antigen-binding fragments thereof, a nucleic acid molecu...
|
|
WO/2023/225405A1 |
A system and method for adaptive laboratory evolution (ALE) employs density stratified layers of cell growth media within a chemostat to form an interface between the layers, creating a gradient with an increasing concentration of a stre...
|
|
WO/2023/221935A1 |
The present invention provides an antibody. The antibody can specifically bind to human CLDN18.2 and human PD-L1. The present invention further provides a nucleic acid molecule encoding the antibody, an expression vector for expressing t...
|
|
WO/2023/218450A1 |
There is provided an isolated fungus belonging to the genus Kazachstania, a composition comprising same, and methods of using same, such as for preventing or treating an infection, a disease, or both.
|
|
WO/2023/219130A1 |
[Problem] To provide a liquid culture medium for improving immunity and promoting normal immune formation, said liquid culture medium promoting human healthy immune formation and curing allergic diseases such as atopic dermatitis, and a ...
|
|
WO/2023/219188A1 |
An embodiment of the present invention provides a culture medium composition for increasing growth and metabolic rates of an acetogenic strain and a method for culturing an acetogenic strain by using same. An embodiment of the present in...
|
|
WO/2023/219437A1 |
The present invention relates to a method for producing lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT) using Corynebacterium glutamicum, and more specifically to: recombinant Corynebacterium glutamicum transformed such that, in or...
|
|
WO/2023/218408A1 |
Provided are methods of identifying bacterial strains capable of colonizing the human female genitourinary tract and compositions thereof, as well as methods of defining vaginal microbial communities and profiles.
|
|
WO/2023/219095A1 |
One aspect of the present disclosure provides a method for preserving a target substance in a target liquid. The method includes: allowing a fiber sheet to absorb the target liquid by bringing the fiber sheet into contact with the target...
|
|
WO/2023/216674A1 |
Provided are a method for preparing a heavy metal passivation material, and a porous biological calcium carbonate-based passivation material with urease activity acquired by means of the method. Based on some specific components, the pas...
|
|
WO/2023/216227A1 |
Provided are a method for preparing a microbial microcapsule and a method for synthesizing a microbial flora (particularly a cross-species microbial flora). According to the principle that chitosan and sodium tripolyphosphate are subject...
|
|
WO/2023/220501A1 |
Disclosed herein are fusion protein, comprising (a) at least one XI domain comprising a. half-life extension compound, including but not limited, to a half-life extension polypeptide; (b) at least one X2 domain comprising an anionic bloc...
|
|
WO/2023/217776A1 |
The present invention relates to methods of aseptically producing filamentous fungi in a bioreactor by pseudo-solid state fermentation. The present invention further relates to methods of continuously, aseptically producing filamentous f...
|
|
WO/2023/217911A1 |
The present invention relates to a genetically modified fungal microorganism for producing glycosidases (EC 3.2.1) in the presence of a simple carbon source as well as to a method for producing glycosidases (EC 3.2.1).
|
|
WO/2023/218898A1 |
The present invention provides: lactic acid bacteria that enhance IL-12p70 and IFN-λ production, thereby making it possible to increases resistance against infection by infectious microorganisms and viruses, relieve stress, and suppress...
|
|
WO/2023/218226A1 |
The present invention relates to a method for growing a biomaterial (7) directly onto a substrate (5) using a floating rafting system (1) over a liquid culturing medium (6) for incubating said biomaterial (7) preventing the need of lamin...
|
|
WO/2023/216685A1 |
The present invention belongs to the technical field of bioengineering. Provided are a strain for synthesizing 2'-fucosyllactose by taking glucose as a carbon source, a construction method therefor, and use thereof. The strain is obtaine...
|
|
WO/2023/219120A1 |
The present invention addresses the problem of providing an anti-CD37/anti-CD3 bispecific antibody that can be used in treatment of humans. The present inventors created multiple anti-CD3scFvs having improved stability and varying affi...
|
|
WO/2023/219160A1 |
The present invention provides a protein having an adjuvant activity of potentiating cellular immunity. More specifically, provided is an adjuvant composition for potentiating cellular immunity, said composition containing a protein havi...
|
|
WO/2023/219458A1 |
The present invention relates to a method of reducing carbon dioxide using microalgae. The carbon dioxide reduction method according to the present invention comprises the steps of: supplying carbon dioxide (CO2)to a first medium within ...
|
|
WO/2023/217056A1 |
The present invention belongs to the technical field of environmental microorganisms, and in particular, provides a composite microbial deodorant, a method for preparing same, and use thereof. The composite microbial deodorant comprises ...
|
|
WO/2023/218130A1 |
Disclosed is a method of producing a fungal biomass (200). The method comprises culturing (202) genetically changed genomes of filamentous fungus (204) on a medium, which comprises non-metabolizable glucose analogue (206) and a growth ca...
|
|
WO/2023/220728A2 |
The present disclosure relates, in part, to microbial hosts capable of synthesizing cis-3-hexenol, cis-3-hexenal, trans-3-hexenol, trans-3-hexenal, trans-2-hexenal, cis-2- hexenal and related compounds from hexanoic acid and methods for ...
|
|
WO/2023/220060A1 |
The disclosure relates to novel methods, compositions, and genetically modified microorganisms for extracting and/or isolating bioproducts from microorganisms having recalcitrant cell walls. In some aspects, the disclosure relates to sol...
|
|
WO/2023/216907A1 |
The present invention relates to the technical field of biology, in particular to a 5'UTR fragment, a biological material, a method for shortening the length of a main stem of a cucurbitaceous plant, and a related product. The 5'UTR frag...
|
|
WO/2023/218197A1 |
The present invention relates to biopesticides and their use in crop protection. In particular the present invention relates to modified Paraburkholderia cells comprising a heterologous biosynthetic gene cluster for producing an antimicr...
|
|
WO/2023/219482A1 |
The invention relates to: an isolated strain of Bacillus thuringiensis var israelensis (RVP BTI-20), deposited with access number CM-CNRG TB193, which exhibits bactericidal activity; a mixture comprising an isolated strain of Bacillus th...
|
|
WO/2023/216565A1 |
Provided are a biological flocculant, a preparation method therefor, and use thereof in blue-green algae treatment. The biological flocculant comprises cationic hydroxyethyl cellulose and an extracellular polysaccharide. The extracellula...
|
|
WO/2023/220281A1 |
The present disclosure provides feed additive compositions and related methods for the treatment and prevention of coinfection with Clostridium bacteria and Eimeria protozoa. The feed additive compositions herein can include a microbial ...
|
|
WO/2023/219300A1 |
The present invention relates to: a Chlorella vulgaris strain deposited with accession number KCTC14768BP; a cosmetic composition, a quasi-drug composition and a food composition for skin improvement, all of which comprise any one or mor...
|
|
WO/2023/219121A1 |
The present invention addresses the problem of providing an anti-TAA/anti-CD3 multispecific antibody that can be used in treatment of humans. In order to produce an anti-TAA/anti-CD3 multispecific antibody that targets various tumor as...
|
